ADIPOQ and Insulin resistance: The term metabolic inflammation is also increasingly used to explain emerging insulin resistance [32] and links the observations that are made with regards to increasing levels of fasting insulin, decreasing adiponectin, elevated PAI-1 and CRP—all findings aligned with the elevated levels of endotoxin.